Parexel saw shares drop 4.3% after releasing information on the embezzlement of corporate funds at one of the company’s international operations in an SEC filing.
Get the full story at our sister site, Medical Design & Outsourcing.
In case you missed it
- Sientra posts Q3 losses, acquires Opus breast implant operation
- Insights from Cathy Burzik’s 40 years in the healthcare industry
- Nihon Kohden introduces ventilator for lung protection
- Dentsply Sirona raises guidance as Q3 earnings beat The Street
- InCarda Therapeutics raises $35 million
- Digital therapeutics company Jogo Health raises $2 million
- Conformis launches next-generation hip system
- 7 innovative medtech leaders you need to know
- DoD awards billions in contracts to Cardinal Health, Owens & Minor
- Indian CDSCO announces medical device, IVD regulatory updates
- FDA puts Class I label on Zimmer Biomet’s Rosa Brain robot software recall
- Endologix rises after posting improved Q3 earnings
- Carlsmed appoints new COO
- Glaukos slides on Q3 profit drop
- BSX prices €900m in senior notes
- 5 ways medtech research aims to help veterans
- EPA proposes drastic cuts to EtO emissions nationwide
MassDevice Network
@MassDevice
LinkedIn
YouTube
Leave a Reply
You must be logged in to post a comment.